Diabetes Research and Clinical Practice

Article	Citations
IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045	2856
Global and regional estimates and projections of diabetes-related health expenditure: Results from the International Diabetes Federation Diabetes Atlas, 9th edition	482
COVID-19 and diabetes: Knowledge in progress	452
Mortality attributable to diabetes in 20–79 years old adults, 2019 estimates: Results from the International Diabetes Federation Diabetes Atlas, 9th edition	351
IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021	279
IDF Diabetes Atlas: Estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group’s Criteria	260
COVID-19, diabetes mellitus and ACE2: The conundrum	242
COVID-19 and diabetes: Can DPP4 inhibition play a role?	242
Diabetes and global ageing among 65–99-year-old adults: Findings from the International Diabetes Federation Diabetes Atlas, 9th edition	236
Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus	213
Diabetes and COVID-19: A systematic review on the current evidences	172
Metformin in COVID-19: A possible role beyond diabetes	155
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration	140
Risk factors for mortality among COVID-19 patients	129
Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed	122
Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients	121
Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19	115
Review of methods for detecting glycemic disorders	106
Impact of COVID-19 lockdown on glycemic control in patients with type 1 diabetes	105
Maternal age and the risk of gestational diabetes mellitus: A systematic review and meta-analysis of over 120 million participants	103
Association of diabetes mellitus with disease severity and prognosis in COVID-19: A retrospective cohort study	97
Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?	95
Geographic distribution of metabolic syndrome and its components in the general adult population: A meta-analysis of global data from 28 million individuals	92
Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes	88
Global estimates of incidence of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Atlas, 10th edition	84

COVID-19 and diabetes management: What should be considered?	83
Increasing prevalence of gestational diabetes mellitus when implementing the IADPSG criteria: A systematic review and meta-analysis	83
The absolute and relative risk of type 2 diabetes after gestational diabetes: A systematic review and meta-analysis of 129 studies	75
Long term outcomes after incident diabetic foot ulcer: Multicenter large cohort prospective study (EDI-FOCUS investigators) epidemiology of diabetic foot complications study	74
Beyond 2020: Modelling obesity and diabetes prevalence	65
Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations	65
COVID-19 infection in Italian people with diabetes: Lessons learned for our future (an experience to be used)	64
The triglyceride–glucose index is a more powerful surrogate marker for predicting the prevalence and incidence of type 2 diabetes mellitus than the homeostatic model assessment of insulin resistance	62
Perceived risk, behavior changes and Health-related outcomes during COVID-19 pandemic: Findings among adults with and without diabetes in China	61
Comorbid diabetes and the risk of disease severity or death among 8807 COVID-19 patients in China: A meta-analysis	60
Hyperglycemia is a strong predictor of poor prognosis in COVID-19	60
GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis	60
High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care	60
Knowledge, attitudes and practices towards COVID-19 among young adults with Type 1 Diabetes Mellitus amid the nationwide lockdown in India: A cross-sectional survey	58
Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in the United Kingdom: A retrospective single centre study	57
School and pre-school children with type 1 diabetes during Covid-19 quarantine: The synergic effect of parental care and technology	57
Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory	56
Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review	55
The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring	55
The International Diabetes Federation’s guide for diabetes epidemiological studies	53
A systematic review, meta-analysis, and meta-regression of the impact of diurnal intermittent fasting during Ramadan on glucometabolic markers in healthy subjects	52
Coronavirus lockdown effect on type 1 diabetes management οn children wearing insulin pump equipped with continuous glucose monitoring system	52
Diabetes and Ramadan: Practical guidelines 2021	51
Testing for gestational diabetes during the COVID-19 pandemic. An evaluation of proposed protocols for the United Kingdom, Canada and Australia	51
Continuous glucose monitoring: The achievement of 100 years of innovation in diabetes technology	51
High admission blood glucose independently predicts poor prognosis in COVID-19 patients: A systematic review and dose-response meta-analysis	49
Cost and cost-effectiveness of mHealth interventions for the prevention and control of type 2 diabetes mellitus: A systematic review	49
The Australian response to the COVID-19 pandemic and diabetes – Lessons learned	47
SARS-CoV-2 and diabetes: New challenges for the disease	46
Liraglutide or insulin glargine treatments improves hepatic fat in obese patients with type 2 diabetes and nonalcoholic fatty liver disease in twenty-six weeks: A randomized placebo-controlled trial	46
Hyperglycemia and COVID-19: What was known and what is really new?	46
Mechanism and application of exosomes in the wound healing process in diabetes mellitus	46
COVID-19 and diabetes: Is metformin a friend or foe?	46
Elevated levels of circulating short-chain fatty acids and bile acids in type 2 diabetes are linked to gut barrier disruption and disordered gut microbiota	45
Demographic and clinical features of critically ill patients with COVID-19 in Greece: The burden of diabetes and obesity	45
The impact of COVID-19 on people with diabetes in Brazil	44
Association is not prediction: A landscape of confused reporting in diabetes – A systematic review	44
Association of diabetes and hypertension with disease severity in covid-19 patients: A systematic literature review and exploratory meta-analysis	44
Type 1 diabetes triggered by covid-19 pandemic: A potential outbreak?	43
The association of periodontal disease with the complications of diabetes mellitus. A systematic review	43
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence	43
Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression	42
Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomised trial	42
Impact of COVID-19 pandemic on glycemic control among outpatients with type 2 diabetes in Japan: A hospital-based survey from a country without lockdown	42
Diabetes and COVID-19: Global and regional perspectives	40
The role of the microbiome in diabetes mellitus	39
Baseline characteristics and risk factors for short-term outcomes in 132 COVID-19 patients with diabetes in Wuhan China: A retrospective study	38
Sustainable diabetes care services during COVID-19 pandemic	37
Caring for a child with type 1 diabetes during COVID-19 lockdown in a developing country: Challenges and parents’ perspectives on the use of telemedicine	37
COVID-19 pandemic: Impact on gestational diabetes mellitus prevalence	37

Worldwide estimates of incidence of type 2 diabetes in children and adolescents in 2021	37
Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia	36
Clinical characteristics and outcome of hospitalized COVID-19 patients with diabetes: A single-center, retrospective study in Iran	36
Coronavirus disease (Covid-19): How does the exercise practice in active people with type 1 diabetes change? A preliminary survey	36
Association between plasma uric acid and insulin resistance in type 2 diabetes: A Mendelian randomization analysis	35
The bidirectional association between diabetes and long-COVID-19 – A systematic review	35
Exosomal lncRNA KLF3-AS1 derived from bone marrow mesenchymal stem cells stimulates angiogenesis to promote diabetic cutaneous wound healing	34
Type 1 diabetes and COVID-19: The “lockdown effect”	34
TIR generated by continuous glucose monitoring is associated with peripheral nerve function in type 2 diabetes	34
Fasting blood glucose level is a predictor of mortality in patients with COVID-19 independent of diabetes history	32
Risk and adverse outcomes of gestational diabetes in migrants: A population cohort study	32
The functions of LncRNA in the heart	32
Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy	31
The impact of a prolonged lockdown and use of telemedicine on glycemic control in people with type 1 diabetes during the COVID-19 outbreak in Saudi Arabia	31
Managing gestational diabetes mellitus using a smartphone application with artificial intelligence (SineDie) during the COVID-19 pandemic: Much more than just telemedicine	31
The effects of Ramadan intermittent fasting on liver function in healthy adults: A systematic review, meta-analysis, and meta-regression	31
Clinical characteristics and outcome in patients with combined diabetic ketoacidosis and hyperosmolar hyperglycemic state associated with COVID-19: A retrospective, hospital-based observational case s	31
A proposed mechanism for the possible therapeutic potential of Metformin in COVID-19	31
Weight stigma and diabetes stigma in U.S. adults with type 2 diabetes: Associations with diabetes self-care behaviors and perceptions of health care	31
The prognostic value of the triglyceride glucose index in patients with chronic heart failure and type 2 diabetes: A retrospective cohort study	31
Associations between depression and cognition, mild cognitive impairment and dementia in persons with diabetes mellitus: A systematic review and meta-analysis	31
Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I)	30
Social support and self-care outcomes in adults with diabetes: The mediating effects of self-efficacy and diabetes distress. Results of the second diabetes MILES – Australia (MILES-2) study	30
Intermittent fasting versus continuous energy-restricted diet for patients with type 2 diabetes mellitus and metabolic syndrome for glycemic control: A systematic review and meta-analysis of randomize	29
Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?	29
Psychiatric disorders as risk factors for type 2 diabetes: An umbrella review of systematic reviews with and without meta-analyses	29
Prevalence of diabetes mellitus in 2019 novel coronavirus: A meta-analysis	29
Incidence and prevalence of hypoglycaemia in type 1 and type 2 diabetes individuals: A systematic review and meta-analysis	29
Efficacy of SGLT-2 inhibitors in older adults with diabetes: Systematic review with meta-analysis of cardiovascular outcome trials	29
Triglyceride to HDL-cholesterol ratio and the incidence risk of type 2 diabetes in community dwelling adults: A longitudinal 12-year analysis of the Korean Genome and Epidemiology Study	28
Impact of COVID-19 lockdown on glucose control of elderly people with type 2 diabetes in Italy	28
Improvement of NRF2 gene expression and antioxidant status in patients with type 2 diabetes mellitus after supplementation with omega-3 polyunsaturated fatty acids: A double-blind randomised placebo-c	28
A systematic review examining the effects of sodium-glucose cotransporter-2 inhibitors (SGLT2is) on biomarkers of inflammation and oxidative stress	28
Management of patients with diabetes and obesity in the COVID-19 era: Experiences and learnings from South and East Europe, the Middle East, and Africa	28
Amelioration of user experiences and glycaemic outcomes with an Advanced Hybrid Closed Loop System in a real-world clinical setting	28
The association of diabetes and the prognosis of COVID-19 patients: A retrospective study	27
Prevalence of diabetes, management and outcomes among Covid-19 adult patients admitted in a specialized tertiary hospital in Riyadh, Saudi Arabia	27
Allergic contact dermatitis in pediatric patients with type 1 diabetes: An emerging issue	27
Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Results from the SURE Switzerland multicentre, prospective, observational study	27
Cognitive function among older adults with diabetes and prediabetes, NHANES 2011–2014	27
The future of insulin therapy	27
Exosomes from linc00511-overexpressing ADSCs accelerates angiogenesis in diabetic foot ulcers healing by suppressing PAQR3-induced Twist1 degradation	26
Waist-to-height ratio has a stronger association with cardiovascular risks than waist circumference, waist-hip ratio and body mass index in type 2 diabetes	26
Type 2 diabetes and viral infection; cause and effect of disease	26
COVID19 in South Asians/Asian Indians: Heterogeneity of data and implications for pathophysiology and research	26
The effect of metformin on mortality and severity in COVID-19 patients with diabetes mellitus	26
Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: A retrospective cohort study	26
Effects of probiotic supplementation during pregnancy on metabolic outcomes: A systematic review and meta-analysis of randomized controlled trials	26
Artificial Intelligence (AI) based machine learning models predict glucose variability and hypoglycaemia risk in patients with type 2 diabetes on a multiple drug regimen who fast during ramadan (The P	26
Gut microbiota and gestational Diabetes Mellitus: A systematic review	25
IDF Diabetes Atlas: The prevalence of pre-existing diabetes in pregnancy – A systematic review and meta-analysis of studies published during 2010–2020	25
Incidence of COVID-19 infection and prevalence of diabetes, obesity and hypertension according to altitude in Peruvian population	25
Novel strategies for glycaemic control and preventing diabetic complications applying the clustering-based classification of adult-onset diabetes mellitus: A perspective	25
Is DPP4 inhibition a comrade or adversary in COVID-19 infection	25
Well-controlled vs poorly-controlled diabetes in patients with COVID-19: Are there any differences in outcomes and imaging findings?	25
Effect of bempedoic acid on new onset or worsening diabetes: A meta-analysis	25
Differential gut microbiota composition between type 2 diabetes mellitus patients and healthy controls: A systematic review	25
Glycaemic control during the lockdown for COVID-19 in adults with type 1 diabetes: A meta-analysis of observational studies	25
Real-world safety and effectiveness of insulin glargine 300 U/mL in participants with type 2 diabetes who fast during Ramadan: The observational ORION study	25
Prevalence of prediabetes and undiagnosed type 2 diabetes in France: Results from the national survey ESTEBAN, 2014–2016	24
Exposure to Gestational Diabetes Mellitus (GDM) alters DNA methylation in placenta and fetal cord blood	24
The associations between fasting plasma glucose levels and mortality of COVID-19 in patients without diabetes	24
REPRINT OF: CLASSIFICATION OF DIABETES MELLITUS	24
Our language matters: Improving communication with and about people with diabetes. A position statement by Diabetes Australia	24
Widespread sensory neuropathy in diabetic patients hospitalized with severe COVID-19 infection	24
A position statement on screening and management of prediabetes in adults in primary care in Australia	24
Prevalence of diabetes and prediabetes and its risk factors in adults aged 25–64 in the Czech Republic: A cross-sectional study	24
The contribution of diabetic micro-angiopathy to adverse outcomes in COVID-19	24
Regression from prediabetes to normal glucose levels is more frequent than progression towards diabetes: The CRONICAS Cohort Study	24
Factors contributing to glycemic control in diabetes mellitus patients complying with home quarantine during the coronavirus disease 2019 (COVID-19) epidemic	23
miR-221-3p and miR-222-3p downregulation promoted osteogenic differentiation of bone marrow mesenchyme stem cells through IGF-1/ERK pathway under high glucose condition	23
J-shaped association between fasting blood glucose levels and COVID-19 severity in patients without diabetes	23
Mesenchymal stem cells modified with angiotensin-converting enzyme 2 are superior for amelioration of glomerular fibrosis in diabetic nephropathy	23
The genus Sutterella is a potential contributor to glucose metabolism improvement after Roux-en-Y gastric bypass surgery in T2D	23
Comparison of effects of SGLT-2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in type 2 diabetes mellitus patients with/without albuminuria: A systematic review and netwo	23
Effectiveness of ketoacidosis prevention campaigns at diagnosis of type 1 diabetes in children: A systematic review and meta-analysis	23
Risk of amputation associated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of five randomized controlled trials	22
Effects of work status changes and perceived stress on glycaemic control in individuals with type 1 diabetes during COVID-19 lockdown in Italy	22
The evolution of insulin therapy	22
SARS-CoV-2 and DPP4 inhibition: Is it time to pray for Janus Bifrons?	22

Efficacy and safety of the glucagon-like peptide-1 receptor agonist oral semaglutide in patients with type 2 diabetes mellitus: A systematic review and meta-analysis	21
COVID-19 impact on people with diabetes in South and Central America (SACA region)	21
Triglyceride and glucose index and the risk of gestational diabetes mellitus: A nationwide population-based cohort study	21
Metformin, neutrophils and COVID-19 infection	21
Direct medical costs of diabetes and its complications in Vietnam: A national health insurance database study	21
Relationship between diabetic neuropathic pain and comorbidity. Their impact on pain intensity, diabetes complications and quality of life in patients with type-2 diabetes mellitus	21
Development and validation of an incidence risk prediction model for early foot ulcer in diabetes based on a high evidence systematic review and meta-analysis	21
The DAR 2020 Global survey: Ramadan fasting during COVID 19 pandemic and the impact of older age on fasting among adults with Type 2 diabetes	20
Associations between retinal microvasculature/microstructure and renal function in type 2 diabetes patients with early chronic kidney disease	20
Meta-analysis of average change in laboratory-measured HbA1c among people with type 1 diabetes mellitus using the 14 day Flash Glucose Monitoring System	20
Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths	20
Considerations for people with diabetes during the Coronavirus Disease (COVID-19) pandemic	20
Diabetes and acute bacterial skin and skin structure infections	20
Invited review. Series: Implications of the recent CVOTs in type 2 diabetes	20
Management of diabetic persons with foot ulceration during COVID-19 health care emergency: Effectiveness of a new triage pathway	20
Diabetic foot ulcer disease in African continent: ‘From clinical care to implementation’ – Review of diabetic foot in last 60 years – 1960 to 2020	20
Brain oxidative stress and cognitive function in older adults with diabetes and pre-diabetes who are at risk for dementia	20
Management of dyslipidemia and atherosclerotic cardiovascular risk in prediabetes	20
A case presentation for positive SARS-CoV-2 RNA recurrence in a patient with a history of type 2 diabetes that had recovered from severe COVID-19	19
Maggot excretions/secretions promote diabetic wound angiogenesis via miR18a/19a – TSP-1 axis	19
Use of metformin and risk of breast and colorectal cancer	19
Lower levels of irisin in patients with type 2 diabetes mellitus: A meta-analysis	19
Microbiota thrombus colonization may influence athero-thrombosis in hyperglycemic patients with ST segment elevation myocardialinfarction (STEMI). Marianella study	19
Screening strategies for nonalcoholic fatty liver disease in type 2 diabetes: Insights from NHANES 2005–2016	19
COVID-19 and type 1 diabetes: Challenges and actions	19
Prevalence of microvascular and macrovascular disease in the Glycemia Reduction Approaches in Diabetes - A Comparative Effectiveness (GRADE) Study cohort	19
The impact of hypoglycaemia on quality of life outcomes among adults with type 1 diabetes: A systematic review	19
The effect of Ramadan focused education on patients with type 2 diabetes: A systematic review and meta-analysis	19
Time-in-range for monitoring glucose control: Is it time for a change?	19
Diabetes self-management education and support for adults with newly diagnosed type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials	19
Should weight-bearing activity be reduced during healing of plantar diabetic foot ulcers, even when using appropriate offloading devices?	18
Antibiotic resistance in diabetic foot infection: how it changed with COVID-19 pandemic in a tertiary care center	18
Heart failure outcomes and Covid-19	18
Effect of different dietary approaches compared with a regular diet on systolic and diastolic blood pressure in patients with type 2 diabetes: A systematic review and meta-analysis	18
Pleiotropic effects of SGLT2 inhibitors and heart failure outcomes	18
A real-world study in patients with type 2 diabetes mellitus treated with gliclazide modified-release during fasting: DIA-RAMADAN	18
Breastfeeding during the COVID-19 pandemic: Suggestions on behalf of woman study group of AMD	18
Changes in the gut microbiome influence the hypoglycemic effect of metformin through the altered metabolism of branched-chain and nonessential amino acids	18
Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus	18
Assessing readiness for independent self-care in adolescents with type 1 diabetes: Introducing the RISQ	18
Microvascular disease and cardiovascular outcomes among individuals with type 2 diabetes	18
Progress toward molecular therapy for diabetes mellitus: A focus on targeting inflammatory factors	18
Diabetes care during COVID-19 lockdown at a tertiary care centre in India	18
Blood-based analysis of 84 microRNAs identifies molecules deregulated in individuals with type-2 diabetes, risk factors for the disease or metabolic syndrome	18
Prevalence of elevated liver stiffness in patients with type 1 and type 2 diabetes: A systematic review and meta-analysis	18
Lack of type 1 diabetes involvement in SARS-COV-2 population: Only a particular coincidence?	18
Ramadan fasting in people with type 1 diabetes during COVID-19 pandemic: The DaR Global survey	17
COVID-19 pandemic: Can fasting plasma glucose and HbA1c replace the oral glucose tolerance test to screen for hyperglycaemia in pregnancy?	17
Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: Results from the CORONADO study	17
Diabetes and COVID-19: The potential role of mTOR	17
Comparative efficacy and safety of 8 GLP-1RAs in patients with type 2 diabetes: A network meta-analysis	17
Association between the reduction of face-to-face appointments and the control of patients with type 2 diabetes mellitus during the Covid-19 pandemic in Catalonia	17
Physical activity in pregnancy prevents gestational diabetes: A meta-analysis	17
Oral glucose tolerance test results in early pregnancy: A Finnish population-based cohort study	17
H(ome)bA1c testing and telemedicine: High satisfaction of people with diabetes for diabetes management during COVID-19 lockdown	17
COVID-19 induced Diabetes: A novel presentation	16
Effect of structured individualized education on continuous glucose monitoring use in poorly controlled patients with type 1 diabetes: A randomized controlled trial	16
Stress hyperglycemia ratio, rather than admission blood glucose, predicts in-hospital mortality and adverse outcomes in moderate-to severe COVID-19 patients, irrespective of pre-existing glycemic stat	16
Effect of different exercise training intensities on musculoskeletal and neuropathic pain in inactive individuals with type 2 diabetes – Preliminary randomised controlled trial	16
Long-term glycemic variability and risk of adverse health outcomes in patients with diabetes: A systematic review and meta-analysis of cohort studies	16
FOXM1 accelerates wound healing in diabetic foot ulcer by inducing M2 macrophage polarization through a mechanism involving SEMA3C/NRP2/Hedgehog signaling	16
Durable metabolic improvements 2 years after duodenal mucosal resurfacing (DMR) in patients with type 2 diabetes (REVITA-1 Study)	16
Medication adherence in young adults with youth-onset type 2 diabetes: iCount, an observational study	16
Identifying features of a mobile-based application for self-care of people living with T2DM	16
Periconceptional iron supplementation and risk of gestational diabetes mellitus: A prospective cohort study	16
How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 System	16
Associations between glycosylated hemoglobin level at less than 24 weeks of gestation and adverse pregnancy outcomes in Japan: The Japan Environment and Children’s Study (JECS)	16
A real-world comparison of cardiovascular, medical and costs outcomes in new users of SGLT2 inhibitors versus GLP-1 agonists	16
The effect of the COVID-19 pandemic on telemedicine in pediatric diabetes centers in Italy: Results from a longitudinal survey	15
Body-weight fluctuation and risk of diabetes in older adults: The China Health and Retirement Longitudinal Study (CHARLS)	15
Prediction of complications of type 2 Diabetes: A Machine learning approach	15
Association between intake of white rice and incident type 2 diabetes – An updated meta-analysis	15
Differential loss of β-cell function in youth vs. adults following treatment withdrawal in the Restoring Insulin Secretion (RISE) study	15
Flash Glucose Monitoring in the Netherlands: Increased monitoring frequency is associated with improvement of glycemic parameters	15
Association between obesity, inflammation and insulin resistance: Insights into signaling pathways and therapeutic interventions	15
Diabetic retinopathy is independently associated with increased risk of intubation: A single centre cohort study of patients with diabetes hospitalised with COVID-19	15
Early pregnancy prediction of gestational diabetes mellitus risk using prenatal screening biomarkers in nulliparous women	15
Significant liver fibrosis, as assessed by fibroscan, is independently associated with chronic vascular complications of type 2 diabetes: A multicenter study	15
Use of SGLT2 inhibitors during Ramadan: An expert panel statement	15
Long-term effectiveness and safety of quadruple combination therapy with empagliflozin versus dapagliflozin in patients with type 2 diabetes: 3-year prospective observational study	15
Systematic review of clinical practice guidelines to identify recommendations for sleep in type 2 diabetes mellitus management	15
Cumulative exposure to impaired fasting glucose and future risk of type 2 diabetes mellitus	15
Irisin rescues diabetic cardiac microvascular injury via ERK1/2/Nrf2/HO-1 mediated inhibition of oxidative stress	15
Combined exercise training improves specific domains of cognitive functions and metabolic markers in middle-aged and older adults with type 2 diabetes mellitus	15
Are spexin levels associated with metabolic syndrome, dietary intakes and body composition in children?	15
COVID-19 associated with diabetes and other noncommunicable diseases led to a global health crisis	15
Gestational diabetes in Korea: Temporal trends in prevalence, treatment, and short-term consequences from a national health insurance claims database between 2012 and 2016	14
Association of advanced glycation end products with diabetic retinopathy in type 2 diabetes mellitus	14
Metabolic changes induced by dapagliflozin, an SGLT2 inhibitor, in Japanese patients with type 2 diabetes treated by oral anti-diabetic agents: A randomized, clinical trial	14
Relationship between diabetes and risk of gastric cancer: A systematic review and meta-analysis of cohort studies	14
Performance of early pregnancy HbA1c for predicting gestational diabetes mellitus and adverse pregnancy outcomes in obese European women	14
The challenge of diabetes home control in COVID-19 times: Proof is in the pudding	14
Therapeutic effect of continuous diffusion of oxygen therapy combined with traditional moist wound dressing therapy in the treatment of diabetic foot ulcers	14
Characteristics of patients with diabetes hospitalised for COVID-19 infection-a brief case series report	14
Short-term safety profile of Sars-Cov2 vaccination on glucose control: Continuous glucose monitoring data in people with autoimmune diabetes	14